Scheifele et al developed criteria for evaluating injection site reactions following vaccination. These can help describe the severity of the reactions seen. The authors are from the University of British Columbia in Vancouver.
Parameters:
(1) erythema (redness)
(2) swelling
(3) tenderness
(4) impaired arm mobility
Parameter |
Finding |
Grade |
erythema |
none or < 5 mm |
none |
|
5 - 19 mm |
mild |
|
20 - 49 mm |
mild to moderate |
|
50 - 99 mm |
moderate |
|
>= 100 mm |
severe |
swelling |
none or < 5 mm |
none |
|
5 - 19 mm |
mild |
|
20 - 49 mm |
mild to moderate |
|
50 - 99 mm |
moderate |
|
>= 100 mm |
severe |
tenderness |
none |
none |
|
discernable effect but well-tolerated |
mild |
|
some limitation of function |
moderate |
|
severe limitation of function and activities of daily living |
severe |
impaired arm mobility |
normal |
none |
|
discernable effect but well-tolerated |
mild |
|
some limitation of function |
moderate |
|
severe limitation of function and activities of daily living |
severe |
Additional findings:
(1) fever (>= 38°C)
(2) skin rash
(3) headache
(4) vomiting
(5) respiratory symptoms
Specialty: Infectious Diseases, Pharmacology, clinical
ICD-10: ,